Literature DB >> 2497696

Blast injuries of the ear in military operations.

Y Y Phillips1, J T Zajtchuk.   

Abstract

Exposure to blast waves from the explosion of ordnance is a common feature of combat operations. The ear is the organ most sensitive to such strong pressure waves. Blast damage to the ear may range from minor acoustic trauma to major disruption of middle and inner ear structures. Standard hearing protectors should offer a significant degree of shielding from these injuries. Aural injury alone seldom should cause a soldier to abandon a combat mission. However, the potential for a large temporary or permanent neurosensory hearing loss does raise issues about such a soldier's effectiveness on the modern, communication-intensive battlefield. Further research is necessary on mechanisms of injury, protective measures, and the effect of hearing loss on military performance.

Entities:  

Mesh:

Year:  1989        PMID: 2497696     DOI: 10.1177/00034894890980s501

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  4 in total

1.  Functional effects of repeated pressure loads upon the tympanic membrane: mechanical stiffness measurements after simulated habitual sniffing.

Authors:  Magnus von Unge; Joris J Dircks
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-08       Impact factor: 2.503

2.  Relationship between changes in the cochlear blood flow and disorder of hearing function induced by blast injury in guinea pigs.

Authors:  Wei Chen; Jianmin Wang; Jing Chen; Jichuan Chen; Zhiqiang Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 3.  Understanding blast-induced neurotrauma: how far have we come?

Authors:  Ibolja Cernak
Journal:  Concussion       Date:  2017-06-08

4.  Evaluation of Patients with Post-Traumatic Hearing Loss: A Retrospective Review of 506 Cases.

Authors:  Mehmet Yilmaz Alpsoy; Said Sönmez; Zeynep Orhan; Elif Kocasoy Orhan; Hizir Aslıyüksek; Kadir Serkan Orhan
Journal:  J Int Adv Otol       Date:  2021-05       Impact factor: 1.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.